NOXXON Pharma's IPO

NOXXON Pharma raised a round of funding on September 30, 2016. Investors include Public.

NOXXON Pharma is a clinical-stage biopharmaceutical company whose core focus is on improving cancer treatment by targeting the tumor microenvironment. NOXXON's goal is to significantly enhance the eff…

Articles about NOXXON Pharma's IPO: